153 related articles for article (PubMed ID: 24769340)
1. Serum acid sphingomyelinase is upregulated in chronic hepatitis C infection and non alcoholic fatty liver disease.
Grammatikos G; Mühle C; Ferreiros N; Schroeter S; Bogdanou D; Schwalm S; Hintereder G; Kornhuber J; Zeuzem S; Sarrazin C; Pfeilschifter J
Biochim Biophys Acta; 2014 Jul; 1841(7):1012-20. PubMed ID: 24769340
[TBL] [Abstract][Full Text] [Related]
2. Association between plasma interleukin-18 levels and liver injury in chronic hepatitis C virus infection and non-alcoholic fatty liver disease.
Vecchiet J; Falasca K; Cacciatore P; Zingariello P; Dalessandro M; Marinopiccoli M; D'Amico E; Palazzi C; Petrarca C; Conti P; Pizzigallo E; Guagnano MT
Ann Clin Lab Sci; 2005; 35(4):415-22. PubMed ID: 16254258
[TBL] [Abstract][Full Text] [Related]
3. Variations in serum sphingolipid levels associate with liver fibrosis progression and poor treatment outcome in hepatitis C virus but not hepatitis B virus infection.
Grammatikos G; Ferreiros N; Bon D; Schwalm S; Dietz J; Berkowski C; Fitting D; Herrmann E; Zeuzem S; Sarrazin C; Pfeilschifter J
Hepatology; 2015 Mar; 61(3):812-22. PubMed ID: 25348752
[TBL] [Abstract][Full Text] [Related]
4. Increased lipid peroxidation in patients with non-alcoholic fatty liver disease and chronic hepatitis C as measured by the plasma level of 8-isoprostane.
Konishi M; Iwasa M; Araki J; Kobayashi Y; Katsuki A; Sumida Y; Nakagawa N; Kojima Y; Watanabe S; Adachi Y; Kaito M
J Gastroenterol Hepatol; 2006 Dec; 21(12):1821-5. PubMed ID: 17074020
[TBL] [Abstract][Full Text] [Related]
5. Hepatic fatty acid translocase CD36 upregulation is associated with insulin resistance, hyperinsulinaemia and increased steatosis in non-alcoholic steatohepatitis and chronic hepatitis C.
Miquilena-Colina ME; Lima-Cabello E; Sánchez-Campos S; García-Mediavilla MV; Fernández-Bermejo M; Lozano-Rodríguez T; Vargas-Castrillón J; Buqué X; Ochoa B; Aspichueta P; González-Gallego J; García-Monzón C
Gut; 2011 Oct; 60(10):1394-402. PubMed ID: 21270117
[TBL] [Abstract][Full Text] [Related]
6. Serum sphingolipidomic analyses reveal an upregulation of C16-ceramide and sphingosine-1-phosphate in hepatocellular carcinoma.
Grammatikos G; Schoell N; Ferreirós N; Bon D; Herrmann E; Farnik H; Köberle V; Piiper A; Zeuzem S; Kronenberger B; Waidmann O; Pfeilschifter J
Oncotarget; 2016 Apr; 7(14):18095-105. PubMed ID: 26933996
[TBL] [Abstract][Full Text] [Related]
7. Circulating microRNAs in patients with chronic hepatitis C and non-alcoholic fatty liver disease.
Cermelli S; Ruggieri A; Marrero JA; Ioannou GN; Beretta L
PLoS One; 2011; 6(8):e23937. PubMed ID: 21886843
[TBL] [Abstract][Full Text] [Related]
8. Evaluation of the role of secretory sphingomyelinase and bioactive sphingolipids as biomarkers in hemophagocytic lymphohistiocytosis.
Jenkins RW; Clarke CJ; Lucas JT; Shabbir M; Wu BX; Simbari F; Mueller J; Hannun YA; Lazarchick J; Shirai K
Am J Hematol; 2013 Nov; 88(11):E265-72. PubMed ID: 23828274
[TBL] [Abstract][Full Text] [Related]
9. Association of serum adipocytokines with insulin resistance and liver injury in patients with chronic hepatitis C genotype 4.
Khattab MA; Eslam M; Aly MM; Shatat M; Hussen A; Moussa YI; Elsaghir G; Abdalhalim H; Aly A; Gaber S; Harrison SA
J Clin Gastroenterol; 2012; 46(10):871-9. PubMed ID: 22664476
[TBL] [Abstract][Full Text] [Related]
10. Enhanced expression of pro-inflammatory mediators and liver X-receptor-regulated lipogenic genes in non-alcoholic fatty liver disease and hepatitis C.
Lima-Cabello E; García-Mediavilla MV; Miquilena-Colina ME; Vargas-Castrillón J; Lozano-Rodríguez T; Fernández-Bermejo M; Olcoz JL; González-Gallego J; García-Monzón C; Sánchez-Campos S
Clin Sci (Lond); 2011 Mar; 120(6):239-50. PubMed ID: 20929443
[TBL] [Abstract][Full Text] [Related]
11. High biological variation of serum hyaluronic acid and Hepascore, a biochemical marker model for the prediction of liver fibrosis.
Rossi E; Adams LA; Ching HL; Bulsara M; MacQuillan GC; Jeffrey GP
Clin Chem Lab Med; 2013 May; 51(5):1107-14. PubMed ID: 23152415
[TBL] [Abstract][Full Text] [Related]
12. Alcoholic and non-alcoholic fatty liver disease: Focus on ceramide.
Nikolova-Karakashian M
Adv Biol Regul; 2018 Dec; 70():40-50. PubMed ID: 30455063
[TBL] [Abstract][Full Text] [Related]
13. Serum apoptotic caspase activity in chronic hepatitis C and nonalcoholic Fatty liver disease.
Papatheodoridis GV; Hadziyannis E; Tsochatzis E; Georgiou A; Kafiri G; Tiniakos DG; Margariti K; Manolakopoulos S; Manesis EK; Archimandritis AJ
J Clin Gastroenterol; 2010 Apr; 44(4):e87-95. PubMed ID: 19881359
[TBL] [Abstract][Full Text] [Related]
14. Parallel expression profiling of hepatic and serum microRNA-122 associated with clinical features and treatment responses in chronic hepatitis C patients.
Butt AM; Raja AJ; Siddique S; Khan JS; Shahid M; Tayyab GU; Minhas Z; Umar M; Idrees M; Tong Y
Sci Rep; 2016 Feb; 6():21510. PubMed ID: 26898400
[TBL] [Abstract][Full Text] [Related]
15. Increased soluble CD36 is linked to advanced steatosis in nonalcoholic fatty liver disease.
García-Monzón C; Lo Iacono O; Crespo J; Romero-Gómez M; García-Samaniego J; Fernández-Bermejo M; Domínguez-Díez A; Rodríguez de Cía J; Sáez A; Porrero JL; Vargas-Castrillón J; Chávez-Jiménez E; Soto-Fernández S; Díaz A; Gallego-Durán R; Madejón A; Miquilena-Colina ME
Eur J Clin Invest; 2014 Jan; 44(1):65-73. PubMed ID: 24134687
[TBL] [Abstract][Full Text] [Related]
16. Status of essential trace minerals and oxidative stress in viral hepatitis C patients with nonalcoholic fatty liver disease.
Guo CH; Chen PC; Ko WS
Int J Med Sci; 2013; 10(6):730-7. PubMed ID: 23630437
[TBL] [Abstract][Full Text] [Related]
17. Reduced heme oxygenase-1 expression in steatotic livers infected with hepatitis C virus.
Abdalla MY; Mathahs MM; Ahmad IM
Eur J Intern Med; 2012 Oct; 23(7):649-55. PubMed ID: 22939811
[TBL] [Abstract][Full Text] [Related]
18. Post-load insulin resistance is an independent predictor of hepatic fibrosis in virus C chronic hepatitis and in non-alcoholic fatty liver disease.
Svegliati-Baroni G; Bugianesi E; Bouserhal T; Marini F; Ridolfi F; Tarsetti F; Ancarani F; Petrelli E; Peruzzi E; Lo Cascio M; Rizzetto M; Marchesini G; Benedetti A
Gut; 2007 Sep; 56(9):1296-301. PubMed ID: 17392334
[TBL] [Abstract][Full Text] [Related]
19. Serum intercellular adhesion molecule-1 in patients with nonalcoholic steatohepatitis: comparison with alcoholic hepatitis.
Ito S; Yukawa T; Uetake S; Yamauchi M
Alcohol Clin Exp Res; 2007 Jan; 31(1 Suppl):S83-7. PubMed ID: 17331172
[TBL] [Abstract][Full Text] [Related]
20. Hepatitis C virus-associated hypobetalipoproteinemia is correlated with plasma viral load, steatosis, and liver fibrosis.
Petit JM; Benichou M; Duvillard L; Jooste V; Bour JB; Minello A; Verges B; Brun JM; Gambert P; Hillon P
Am J Gastroenterol; 2003 May; 98(5):1150-4. PubMed ID: 12809841
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
